Market Overview

Morning Market Losers

Related SNTA
InterMune's Roche Deal Sends Peer Group Up
Synta Announces Advancement Of Ganetespib Into Phase 3 Extension Of AML LI-1 Study For Patients With AML And High-Risk MDS
Related INFI
Benzinga's Top Upgrades
JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

Synta Pharmaceuticals (NASDAQ: SNTA) shares dipped 32.93% to $4.95 after the company reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of ganetespib in second-line non-small cell lung cancer.

Infinity Pharmaceuticals (NASDAQ: INFI) shares lost 23.41% to $20.64 on Phase 1 data.

Affymax (NASDAQ: AFFY) fell 22.60% to $1.61. Affymax's PEG ratio is -0.17.

National Bank of Greece SA (NYSE: NBG) dropped 12.60% to $6.31. The bank's trailing-twelve-month profit margin is -98.37%

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets

 

Related Articles (AFFY + INFI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters